Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Shares Outstanding (Weighted Average): 2024-2025

Historic Shares Outstanding (Weighted Average) for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $86.8 million.

  • Kura Oncology's Shares Outstanding (Weighted Average) rose 13.26% to $86.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.8 million, marking a year-over-year increase of 13.26%. This contributed to the annual value of $77.8 million for FY2024, which is 4.70% up from last year.
  • Kura Oncology's Shares Outstanding (Weighted Average) amounted to $86.8 million in Q3 2025, which was up 0.26% from $86.6 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Shares Outstanding (Weighted Average) peaked at $86.8 million during Q3 2025, and registered a low of $76.1 million during Q1 2024.
  • Moreover, its 2-year median value for Shares Outstanding (Weighted Average) was $77.8 million (2024), whereas its average is $80.1 million.
  • Data for Kura Oncology's Shares Outstanding (Weighted Average) shows a peak YoY grew of 13.64% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Shares Outstanding (Weighted Average) stood at $77.8 million in 2024, then rose by 13.26% to $86.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $86.8 million in Q3 2025, compared to $86.6 million in Q2 2025 and $80.8 million in Q1 2025.